BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 31, 2021
View Archived Issues
Wave ends clinical development of WVE-120102 and WVE-120101 for Huntington's disease
Read More
New model of MECP2 duplication syndrome may advance antisense oligonucleotide treatment
Read More
Dosing begins in phase I study of DD-01 in obese patients with diabetes and NAFLD
Read More
Pediatric study of CRV-101 against varicella in HIV-positive children approved in South Africa
Read More
FDA approves IND application for phase I study of TJ-CD4B bispecific antibody
Read More
Promising data from first 4 patients treated with BS-01 optogenetic gene therapy
Read More
INSERM and others present monoclonal antibodies targeting IL-20RB
Read More
TaiGen Biotechnology discovers hepatitis B antiviral agents
Read More
Yhhu-2407, novel low systemic DGAT1 inhibitor with potential for the treatment of dyslipidemia
Read More
New agents for encephalitic alphaviruses identified at the Wisconsin Alumni Research Foundation
Read More
The University of Texas System divulges RIP-1 inhibitors
Read More
177Lu-DOTA-EB-TATE is well tolerated and effective in patients with late-stage NETs
Read More
New genetic variants in CD80 found to have prognostic value in prostate cancer
Read More
New SHP-2 inhibitors identified at Sichuan Kelun-Biotech Biopharmaceutical
Read More
Equillium reports data from ongoing phase Ib study of itolizumab in SLE
Read More
China NMPA clears CTA for basket trial of Trodelvy for cancers with high TROP-2 expression
Read More
FDA approves Vyxeos for secondary AML in pediatric patients
Read More
Huyabio signs clinical collaboration agreement for phase III melanoma trial of HBI-8000 with Opdivo
Read More
Squalenoyl siRNA PMP22 nanoparticles developed for Charcot-Marie-Tooth disease type 1 A
Read More
FDA clears initiation of first-in-human study of CRISPR_SCD-001 for sickle cell disease
Read More
Cabometyx with Opdivo approved in E.U. for first-line advanced RCC
Read More
European Commission approves Ontozry for drug-resistant focal-onset seizures in adults
Read More
Disulfiram blocks conformational changes of the complex between human p97 and its cofactor Npl4/Ufd1
Read More
Kamada reports phase I/II topline results on anti-SARS-CoV-2 plasma-derived IgG
Read More
Pivotal topline data on BNT-162b2 in adolescents aged 12-15 years
Read More
ChromaDex announces research initiative to study effects of Niagen and citrin deficiency
Read More
FDA clears IND for phase I/IIa study of AFM-24 with SNK-01 for EGFR-expressing solid tumors
Read More
